These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Assessment of serum vascular endothelial growth factor and nail fold capillaroscopy changes in systemic lupus erythematosus with and without cutaneous manifestations. Moneib HA; Salem SA; Aly DG; Khedr HT; Wafaey HA; Hassan HE J Dermatol; 2012 Jan; 39(1):52-7. PubMed ID: 21950586 [TBL] [Abstract][Full Text] [Related]
14. Markers of inflammation and atherosclerosis in Egyptian patients with systemic lupus erythematosus. Sabry AA; Elbasyouni SR; Kalil AM; Abdel-Rahim M; Mohsen T; Sleem A Nephrology (Carlton); 2006 Aug; 11(4):329-35. PubMed ID: 16889573 [TBL] [Abstract][Full Text] [Related]
15. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus. Robak E; Kierstan M; Cebula B; Krawczynska A; Sysa-Jedrzejowska A; Wierzbowska A; Smolewski P; Robak T Lupus; 2009 Apr; 18(4):332-41. PubMed ID: 19276301 [TBL] [Abstract][Full Text] [Related]
16. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Schiffer L; Kümpers P; Davalos-Misslitz AM; Haubitz M; Haller H; Anders HJ; Witte T; Schiffer M Nephrol Dial Transplant; 2009 Dec; 24(12):3708-12. PubMed ID: 19602475 [TBL] [Abstract][Full Text] [Related]
17. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus. Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695 [TBL] [Abstract][Full Text] [Related]
19. Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus. Lee AB; Godfrey T; Rowley KG; Karschimkus CS; Dragicevic G; Romas E; Clemens L; Wilson AM; Nikpour M; Prior DL; Best JD; Jenkins AJ Intern Med J; 2006 Apr; 36(4):237-43. PubMed ID: 16640741 [TBL] [Abstract][Full Text] [Related]